Hepatocellular carcinoma (HCC) is the third leading cause of cancer death worldwide.
Surveillance for HCC is critical for early detection and treatment, but fewer than one-quarter …

Executive summary Liver diseases have become a major health threat across Europe, and
the face of European hepatology is changing due to the cure of viral hepatitis C and the …

Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death worldwide, in
part because of inadequate early detection strategies. Current recommendations for …

Liver cancer is highly fatal, and death rates in the United States are increasing faster than for
any other cancer, having doubled since the mid‐1980s. In 2017, it is estimated that the …

Background Non‐alcoholic fatty liver disease (NAFLD) and non‐alcoholic steatohepatitis
(NASH) account for an increasing proportion of liver disease in the Asia‐Pacific region …

In the United States, hepatocellular carcinoma (HCC) survival varies with tumor
characteristics, patient comorbidities, and treatment. The effect of HCC etiology on survival is …

The most common primary liver cancer is hepatocellular carcinoma (HCC), and its mortality
rate is increasing globally. The overall 5-year survival of patients with liver cancer is …

Hepatology AASLD Publications Hepatology Liver Transplantation Hepatology
Communications Clinical Liver Disease Log in or Register Subscribe to journalSubscribe Get …

Hepatocellular carcinoma (HCC) is the sixth most common primary malignancy worldwide,
and the third most common cause of death among cancers worldwide. HCC occurs in …

Hepatocellular carcinoma (HCC) arises in the context of cirrhosis and chronic hepatitis B
virus (HBV) infections, and the diagnosis is often made at advanced stages. Because early …